Neuromyelitis optica (NMO) is a severe autoimmune disease of the central nervous system whose clinical spectrum ranges from unilateral isolated optic neuritis to extensive myelitis with bilateral optic neuritis. Dystonia is characterized by sustained muscle contractions, frequently causing twisting and repetitive movements, or abnormal postures. It can be continual or paroxysmal and focal, segmental, multifocal, generalized or hemidystonic according to the bodily distribution. Concerning its etiology, secondary dystonia can originate from lesions in the central (basal ganglia and upper cervical cord) or peripheral nervous system. Our objective was to report four patients with paroxysmal dystonia related to NMO.
MetHODS
Four non-consecutive in-patients with NMO were admitted in our Hospital to treat a relapse between [2008] [2009] . This study was approved by the local ethics committee.
reSUltS
Four female patients were admitted with an acute attack of cervical or cervico-dorsal myelitis. The clinical details of each patient are seen in Table. case histories Patient 1: A 65-year-old woman had a subacute tetraparesis and left visual loss in the 1970' s. She developed many bouts and remissions with progressive atrophy of the distal right arm. In November 2007, during a new bout of subacute tetraparesis, a cervical magnetic ressonance imaging (MRI) revealed an extensive T2 and Flair hyperintense lesion with contrast enhancement with a hypointense lesion suggestive of acute myelitis and also a syrinx. Brain MRI was normal. Cerebrospinal fluid (CSF) was not performed due to her unstable clinical condition. She was then treated with plasmapheresis, IV metilprednisolone and immunoglobulin with mild motor improvement, being able to sit up. During the recovery, she presented with painful kinesigenic paroxysmal dystonic movements in the four limbs, mostly in the upper limbs. Carbamazepine 600 mg/day abolished the abnormal movements. The symptoms worsened in a few weeks and she became paraplegic, with urinary retention, and the sensitive level was in D8. Dorsal MRI showed a hyperintense T2 lesion that extended from D2 to D9 with no contrast enhancement. Brain MRI did not depict any lesions suggestive of multiple sclerosis. CSF exam showed 26 cells (80% lymphocytes), protein=108 mg/dL, glucose=75 mg%, IgG index=0.7 (normal ≤0.85) and failure to demonstrate oligoclonal bands. She was treated with plasmapheresis, IV metilprednisolone and immunoglobulin with marked motor improvement, being able to walk without assistance. During the recovery time, nonkinesigenic paroxysmal dystonia of the lower limbs was noticed and then disappeared after the introduction of carbamazepine 900 mg/day.
Patient 4: A 34-year-old woman presented with bilateral amaurosis in 1998 and she developed numerous attacks of cervical myelitis. A new bout of cervical myelitis resulting in tetraplegia and dyspnea, bilateral amaurosis and marked proprioceptive impairment occured in June 2007. Cervical spinal MRI showed a large hyperintense T1, T2 and Flair lesion. CSF exam revealed 5 cells (100% lymphocytes), protein=35 mg/dL and glucose=51 mg%. IV metilprednisolone and immunoglobulin were introduced with respiratory distress and motor function improvement, and she was then able to walk with assistance. During the recovery time, kynesigenic paroxysmal right hemidystonia was seen and then abolished after the introduction of carbamazepine 600 mg/day.
DiScUSSiON
In 1940, Mount and Reback introduced the concept of paroxysmal type movement disorders while describing attacks of tonic spasms and choreic and athetotic movements in a 23-year-old patient who had had both large (up to 2 hours) and small ( from 5 to 10 minutes) "spells" since infancy 3 . Their work became the seminal paper in the field of paroxysmal dyskinesia (PD) . Since our patients presented with the first two types, we will emphasize only PKD and PNKD.
In the first one, the duration ranges from seconds to five minutes, and the etiology can be primary ( familial or sporadic) or secondary. In the second, the duration ranges from two minutes to four hours, and the etiology can be primary ( familial or sporadic), secondary, alternating hemiplegia of childhood or psychogenic 2 . The overwhelming majority of reported cases in the literature of both types are primary. Although not reported as often, secondary type is probably more common and has been reported to occur in patients with multiple sclerosis, progressive supranuclear palsy, hyperglycemia, spinal cord lesion, subacute sclerosing panencephalitis, Huntington´s disease, HIV infection, medulla oblongata lesions 2 . Paroxysmal dystonia, also called tonic spasm, is an uncommon movement disorder in association with multiple sclerosis (MS) 2, 4 . These abnormal involuntary movements can occur at the initial presentation or at relapses of MS 5, 6 and are known to disappear within a few weeks spontaneously or after steroid treatment. It is believed that tonic spasms occur at any level in a motor path. Otherwise, there is no report in the reviewed literature of PD related to NMO.
PKD associated with pure spinal cord lesions is rare 7, 8 . Cosentino et al. 7 reported a case of PKD associated with an intraspinal lesion. The attacks were precipitated by movement and also by deep nociceptive stimulus. Although the anatomical basis of secondary PKD is variable, the authors believe that a deep sensory system plays an important role in the pathogenesis of the attacks. Brown et al. 9 described a patient with paroxysmal truncal flexion spasms of spinal origin, presumably involving the propriospinal pathways. All of our patients had cervical spinal lesions without brainstem, thalamic or cerebral lesions. All of them had severe transverse myelitis with involvement of the propriospinal pathways. Pathophysiologically, some authors suggest that PD are channelopathies 2 and, since NMO is considered a novel channelopathy (presence of antibodies to water channel aquaporin-4), it is no surprise to find these abnormal movements associated with NMO. It is difficult to explain why these movements occurred at the time of recovery rather than during the acute phase. However, we speculate that the severe damage to the spinal cord did not allow the clinical expression of PD in the acute phase of the NMO. Therefore, we believe that local biochemical imbalance during the period of recovery could have prompted the disinhibition of spinal interneurons and then the onset of PD.
In conclusion, to the best of our knowledge, this is the first description in the literature of paroxysmal dystonia in the course of NMO.
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